We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sigmaroc Plc | LSE:SRC | London | Ordinary Share | GB00BYX5K988 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.70 | 1.13% | 62.80 | 63.00 | 63.20 | 63.10 | 62.00 | 62.00 | 903,038 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 537.99M | 31.24M | 0.0280 | 22.50 | 702.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/8/2021 12:16 | added a few, love this stock.. | wanttowin | |
05/8/2021 07:18 | Liberum TP 125p from 96p | se81 | |
03/8/2021 07:35 | Peel hunt target price of 135p from 105p | arregius | |
02/8/2021 14:53 | Good update. Eps was stimated at 2,5p before. A tiny yet pleasant upgrade | arregius | |
02/8/2021 13:52 | General meeting statement issued. Extract: The Group's trading has also continued to be in-line with management expectations. SigmaRoc generated revenues of £84.8 million and underlying EBITDA of £15.2 million in the six months to 30 June 2021 (unaudited), representing a like-for-like increase of 13 per cent. and 17 per cent. respectively over the same period in 2020. Nordkalk generated revenues of €144.6 million (approximately £126.5 million) and EBITDA of €36.0 million (approximately £31.3 million), representing an increase of 8 per cent. and 17 per cent. respectively over the same period in 2020. SigmaRoc underlying earnings per share for the six month period ended 30 June 2021 is expected to exceed 2.6 pence. | alter ego | |
26/7/2021 08:16 | Cant watch that from spain | arregius | |
24/7/2021 19:28 | Greenblock just seen on Bbc2 Tatton Park flower show around 25 mins into program | alter ego | |
22/7/2021 01:11 | A 5m share sale @95p, reported after the close, saw the shareprice fail to close above 100p. | masurenguy | |
21/7/2021 10:22 | Indeed, I have increased my 12 month target to £1.50 given my last target has been reached of £1.00. | haywards26 | |
21/7/2021 08:34 | Excellent news, with more financial results to be released shortly, this has more growth to come | hsduk101 | |
21/7/2021 08:27 | Assets heavy compounder that will be in my portfolio "forever" | arregius | |
21/7/2021 08:11 | Good to see momentum here, market must like the deal Gla | andyview | |
21/7/2021 08:09 | Has broken the 100p threshold again - can it break through this resistence level and close above it ! | masurenguy | |
20/7/2021 14:34 | Moving back toward the 100p threshhold ! | masurenguy | |
19/7/2021 10:08 | Have they got a new one out? Can't see it on researchtree | otemple3 | |
19/7/2021 09:56 | Liberum note worth a read. Very good | arregius | |
16/7/2021 11:47 | John Rosier mentions Sigmaroc (SRC) in the latest PIWORLD interview at 5m39s Watch the video here: Or listen to the podcast here: | tomps2 | |
16/7/2021 09:48 | I quite like these "blink-and-you'll-mi | bluntnib | |
16/7/2021 09:38 | New shares won't be admitted until late August assuming everything is approved | otemple3 | |
16/7/2021 09:26 | When are the stocks bought on PB sent over, just trying to establish when there will be a dip from people taking profits on bigger holdings. | charlie9038 | |
16/7/2021 08:34 | I was allocated 80% of what I applied for - odd but still a decent chunk. Nice to see the price up reacting well to the deal | otemple3 | |
16/7/2021 08:28 | Nice response from Mr Market though….and I would expect the share price to retest ATH very soon…… | jaf111 | |
16/7/2021 08:26 | Surprised anyone was scaled back in Retail offer since they raised only £1.6m vs £6.5m max limit……& | jaf111 | |
16/7/2021 08:18 | My allocation wasn't scaled back - it was modest in size. Very pleased to have been able to top up. | alter ego |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions